Track record · closed signal

Halozyme Therapeutics, Inc. (HALO) — closed signal from March 4, 2026

Partial Published before the outcome was known, scored automatically when the window closed on June 2, 2026.

Predicted vs. what happened

HALO price · publication thesis → realized outcomesplit-adjusted
$71.06 Published $83.84 Target $66.28 Window close $73.89 Peak
$68.50 – $71.50Entry zone — fair-value band
$71.06Published — price the day we called it
$83.84Target — the price the thesis aimed for
$73.89Peak — highest point inside the window, not a realized return
$66.28Window close — end-of-window price, context only

What happened

Partial

Reached 22% of the predicted growth at its peak, without hitting the target.

Peak price
$73.89
peak on May 12, 2026 — not a realized return
Peak gain
+4%
peak, from the publication price
Window close
$66.28
end-of-window price, context only
Days to target
Window
March 4, 2026 – June 2, 2026

The thesis — published March 4, 2026

Predicted growth
+18%
over the measurement window
Target price
$83.84
the price the thesis aimed for
Entry zone
$68.50 – $71.50
the fair-value band we waited for
Price at publication
$71.06
published March 4, 2026
Confidence
82%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

The stock dropped quickly, which can set up a bounce if selling calms. Positive analyst notes and being included in ETFs can draw buyers back fast. Upcoming management talks are a short-term moment that could reset attention. Because the overall move is still fragile, buy in stages and keep each position size small.

Primary drivers

  • Analyst upgrades can bring new buyers and attention
  • Management presentations can shift investor focus quickly
  • Earnings from royalty deals lower the risk of single trial failure
  • Big selloff may reverse if selling pressure eases

How it played out

HALO: the target was not reached

Lyra published HALO on 2026-03-04 at 71.06 with expected growth of 18%. The thesis pointed to analyst upgrades, management presentations, royalty deal earnings, and the chance that a big selloff could reverse if selling pressure eased.

Inside the window from 2026-03-04 to 2026-06-02, HALO rose to a peak of 73.89 on 2026-05-12, a 4% gain. It stayed below the 83.84 target. The stock ended at 66.28. The thesis only partly played out: there was a bounce, but it was small and did not reach the published target.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.